FDA issued a Warning Letter to Jubilant Generics Limited on 3/6/2019 for a previous inspection.
483 Jubilant Generics Mar 2021

483 Jubilant Generics Mar 2021

Rita Kabaso FDA, Dipesh Shah FDA$119.00 - Available Now

FDA investigators audited the Jubilant Generics - Sikanderpur Bhainswal, India facility and issued inspectional observations (via FDA 483) on 12 Mar 2021.

Product details

  • Category: Human Drugs
  • Inspection end: 12 Mar 2021
  • Location: Sikanderpur Bhainswal, India
  • FEI: 3006895982
Add To Cart